James M. Musser

Active 1985–2025

235
Papers
41,705
Citations
125
h-index
233
i10-index

Citations

Citations per year for James M. Musser1969: 1 citations1985: 1 citations1986: 10 citations1987: 22 citations1988: 29 citations1989: 42 citations1990: 82 citations1991: 63 citations1992: 89 citations1993: 100 citations1994: 89 citations1995: 130 citations1996: 185 citations1997: 163 citations1998: 305 citations1999: 263 citations2000: 305 citations2001: 349 citations2002: 419 citations2003: 503 citations2004: 463 citations2005: 528 citations2006: 494 citations2007: 429 citations2008: 461 citations2009: 472 citations2010: 353 citations2011: 397 citations2012: 334 citations2013: 282 citations2014: 373 citations2015: 272 citations2016: 285 citations2017: 184 citations2018: 183 citations2019: 726 citations2020: 801 citations2021: 796 citations2022: 505 citations2023: 350 citations2024: 514 citations2025: 175 citations2026: 4 citations1970–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,855 citing papers, 30.2% of this breakdownUnited Kingdom: 1,132 citing papers, 8.9% of this breakdownFrance: 697 citing papers, 5.4% of this breakdownGermany: 676 citing papers, 5.3% of this breakdownChina: 497 citing papers, 3.9% of this breakdownAustralia: 410 citing papers, 3.2% of this breakdownCanada: 401 citing papers, 3.1% of this breakdownNetherlands: 340 citing papers, 2.7% of this breakdownItaly: 298 citing papers, 2.3% of this breakdownIndia: 292 citing papers, 2.3% of this breakdownSweden: 271 citing papers, 2.1% of this breakdownSwitzerland: 257 citing papers, 2% of this breakdown
0%30.2%Other 28.6%

Fields

  • Medicine56.9%
  • Biochemistry, Genetics and Molecular Biology22.2%
  • Immunology and Microbiology11.9%
  • Agricultural and Biological Sciences3.3%
  • Environmental Science1.9%
  • Chemistry0.6%
  • Other3.2%

Topics

  • Antimicrobial Resistance in Staphylococcus6.7%
  • Tuberculosis Research and Epidemiology6%
  • Mycobacterium research and diagnosis4.9%
  • Streptococcal Infections and Treatments4.9%
  • Antibiotic Resistance in Bacteria3.7%
  • Bacterial biofilms and quorum sensing3.1%
  • Other70.7%

Coauthors

All papers

Open in search
  1. Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 113

  2. Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae

    Authors: , , , , , , , , , , - Scientific Reports 2018 cited by 197

  3. Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Communications Biology 2022 cited by 64

  4. STAT3 Mutations in the Hyper-IgE Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,204

  5. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 341

  6. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 259

  7. Staphylococcus aureus Aconitase Inactivation Unexpectedly Inhibits Post-Exponential-Phase Growth and Enhances Stationary-Phase Survival

    Authors: , , , , , , - Infection and Immunity 2002 cited by 201

  8. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2022 cited by 221

  9. Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307

    Authors: , , , , , , , , - mBio 2017 cited by 157

  10. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 601

  11. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 267

  12. Evolutionary Origin and Emergence of a Highly Successful Clone of Serotype M1 Group AStreptococcusInvolved Multiple Horizontal Gene Transfer Events

    Authors: , , , , , , , , , , - The Journal of Infectious Diseases 2005 cited by 372

  13. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 342

  14. Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils

    Authors: , , , , , , , , , , , - The Journal of Immunology 2005 cited by 559

  15. Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 393

  16. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia

    Authors: , , , , , , - Journal of Infection 2014 cited by 319

  17. Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update

    Authors: , - Tubercle and Lung Disease 1998 cited by 1,102

  18. Integrating Rapid Pathogen Identification and Antimicrobial Stewardship Significantly Decreases Hospital Costs

    Authors: , , , , , , , - Archives of Pathology & Laboratory Medicine 2012 cited by 385

  19. Environmental pH and peptide signaling control virulence of Streptococcus pyogenes via a quorum-sensing pathway

    Authors: , , , , , , - Nature Communications 2019 cited by 68

  20. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 1997 cited by 336

  21. Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase

    Authors: , , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2003 cited by 262

  22. Integrative Reverse Genetic Analysis Identifies Polymorphisms Contributing to Decreased Antimicrobial Agent Susceptibility in Streptococcus pyogenes

    Authors: , , , , , , - mBio 2022 cited by 34

  23. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol

    Authors: , , , , , , , - Nature Medicine 1997 cited by 461

  24. Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 392